Attractive valuation despite negative revisions

Strong insurance outcome and financials

Strong beat and outlook, but already priced in

Better PTP from non-reccuring items

Strong beat from price increases impact

Stronger insurance and profit sharing

Heads-up for report 11 July

Heads-up for Q2-report, 11 July

Nordic non-life Q2e: A double tailwind

FX tailwind drives revisions

Recovery continues, but reflected in valuation

AUM rebound drives earnings growth

Sampo: 1 director

A director at Sampo bought 5,500 shares at 9.140EUR and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing C...

Analyst Day: On track for '27 targets, but cautious on AI

Norway: Best ideas Q2'25

Nordic non-life insurance – Q1 reporting wrap

Insurance trip: 16 insurers in three days

Non-life have price increases > inflation in all markets, most in Norway. Life insurance growth with rapid growth & dividend payments. Prefer ALMB, Sampo, Solid, Tryg among non-life; STB for life

ROE held back by too-high capital base

Storebrand (Buy, TP: NOK149.00) - Insurance repricing on track

Q1 PTP before amortisation was NOK1,167m, up 8% YOY, driven by strong growth in Banking and Insurance. While high sales activity had a negative impact on the insurance cost ratio, the combined ratio continued to improve through premium growth of 20% YOY, leaving Storebrand close to the 90–92% target for 2025. We have made fairly limited EPS revisions for 2026–2027e, and reiterate our BUY and NOK149 target price.

Sampo Oyj (Buy, TP: EUR10.20) - Strong underwriting momentum

Although Q1 PTP declined by 19% YOY to EUR377m, due to a lower investment result, Sampo continued to see strong underwriting momentum, with 9% YOY GWP growth (in local FX) and a 2.5%-points stronger underlying combined ratio YOY. Based on a better synergy outlook from the integration of Topdanmark, it increased its cost improvement guidance. We have raised our 2026–2027e EPS by ~1% on higher growth and ongoing underwriting improvements. We have raised our target price to EUR10.2 (9.8), and reite...